Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with KGK Science, whereby it will begin studying a psilocybin extract produced in its lab.

The clinical trial is to study the safety and psychoactive properties of a Psilocybe mushroom product that has been extracted and formulated by the study. Classified as a phase 1 trial, the trial is to consist of 14 volunteers that will be used to assess the safety and efficacy of such a product, which will then be used in further trials, or under compassionate-use guidelines.

The study is expected to create IP for the company while also enabling further studies to be conducted in the future.

Numinus Wellness last traded at $1.08 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Emerita Resources Intersects Further Mineralization At El Cura, Expanding Deposit

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

Related News

Roadman Investments To Establish Psychedelic Conference for Investors

Roadman Investments (TSXV: LITT), a firm focused on the production of mushrooms, announced this morning...

Thursday, September 5, 2019, 08:42:39 AM

Numinus Wellness Walks From Acquisition Of MedBright AI

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets...

Monday, August 12, 2024, 10:08:35 AM

Numinus Wellness: A Glance At The Structure

The much anticipated launch of Numinus Wellness (TSXV: NUMI) is scheduled to occur tomorrow. Given...

Tuesday, May 19, 2020, 06:22:53 PM

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally...

Tuesday, December 29, 2020, 04:49:21 PM

Numinus Wellness Parts With Chief Strategy Officer, Issues 2.0 Million Shares With Separation

Numinus Wellness Inc. (TSXV: NUMI) announced on Thursday that its Chief Strategy Officer Stacey Wallin...

Friday, November 26, 2021, 01:08:00 PM